Catalyst Funds Management Pty »

Cognition Therapeutics shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-03-31 $40k 53k 0.76

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Rio Tinto Adr (RIO)
Arm Holdings Adr (ARM)
Astrazeneca Ordinary Shares (AZN)
Medline Ordinary Shares (MDLN)
Cisco Systems Ordinary Shares (CSCO)
Abbvie Ordinary Shares (ABBV)
Teradyne Ordinary Shares (TER)
TechnipFMC Ordinary Shares (FTI)
Elbit Systems Ordinary Shares (ESLT)
Exxon Mobil Corp. Ordinary Shares (XOM)
Walmart Ordinary Shares (WMT)
Cheniere Energy Ordinary Shares (LNG)
Revolution Medicines Ordinary Shares (RVMD)
Valero Energy Corp. Ordinary Shares (VLO)

View all positions for Catalyst Funds Management Pty

Top funds holding Cognition Therapeutics

BIOS Capital Management
Vanguard Group
Vanguard Capital Management
Davenport & Co
Chescapmanager
Renaissance Technologies
BlackRock
Geode Capital Management
Hilton Capital Management
Dauntless Investment Group
Vanguard Fiduciary Trust
CM Management
Jane Street
Sigma Planning
State Street Corporation

View all funds holding Cognition Therapeutics